Literature DB >> 24888332

Novel de novo heterozygous FGFR1 mutation in two siblings with Hartsfield syndrome: a case of gonadal mosaicism.

Radhika Dhamija1, Salman Kirmani, Xiangling Wang, Matthew J Ferber, Eric D Wieben, Konstantinos N Lazaridis, Dusica Babovic-Vuksanovic.   

Abstract

Hartsfield syndrome has been recently reported to be associated with mutations in FGFR1 however, to this date; no familial cases have been reported. In this report, we describe two siblings with Hartsfield syndrome and a novel de novo FGFR1 mutation suggesting gonadal mosaicism. The proband presented at our institution at age 6 years with a clinical diagnosis of Hartsfield syndrome and requesting further genetic evaluation. Previous studies included a normal karyotype, oligonucleotide array, and single gene testing for nonsyndromic holoprosencephaly (SHH, SIX3, ZIC2, TGIF). At the age of 6 years, exome sequencing was performed and a de novo novel missense variant was identified in FGFR1 (coding for fibroblast growth factor-1) on chromosome 8p12: c.1880G>C (p.R627T). Subsequently, a younger sibling was born with the same phenotype (holoprosencephaly, ectrodactyly of bilateral hands and feet and bilateral cleft lip and palate). Targeted sequencing of FGFR1 revealed the identical variant that was previously identified in the proband. To our knowledge this observation is the first documentation of familial recurrence of Hartsfield syndrome. As both parents were negative for the sequence variant in FGFR1 gene by testing peripheral blood samples, this suggests gonadal mosaicism. The frequency of gonadal mosaicism in Hartsfield syndrome is not known however given our case, this possibility should be taken in to consideration for recurrence risk estimation in children of clinically unaffected parents.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  FGFR1 mutation; Hartsfield syndrome; gonadal mosaicism

Mesh:

Substances:

Year:  2014        PMID: 24888332     DOI: 10.1002/ajmg.a.36621

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

1.  A novel dominant-negative FGFR1 variant causes Hartsfield syndrome by deregulating RAS/ERK1/2 pathway.

Authors:  Pietro Palumbo; Antonio Petracca; Roberto Maggi; Tommaso Biagini; Grazia Nardella; Michele Carmine Sacco; Elia Di Schiavi; Massimo Carella; Lucia Micale; Marco Castori
Journal:  Eur J Hum Genet       Date:  2019-02-20       Impact factor: 4.246

2.  Loss-of-function mutations in FGF8 can be independent risk factors for holoprosencephaly.

Authors:  Sungkook Hong; Ping Hu; Erich Roessler; Tommy Hu; Maximilian Muenke
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

3.  Dominant-negative kinase domain mutations in FGFR1 can explain the clinical severity of Hartsfield syndrome.

Authors:  Sungkook Hong; Ping Hu; Juliana Marino; Sophia B Hufnagel; Robert J Hopkin; Alma Toromanović; Antonio Richieri-Costa; Lucilene A Ribeiro-Bicudo; Paul Kruszka; Erich Roessler; Maximilian Muenke
Journal:  Hum Mol Genet       Date:  2016-02-29       Impact factor: 6.150

4.  Novel heterozygous mutation in the extracellular domain of FGFR1 associated with Hartsfield syndrome.

Authors:  Masaki Takagi; Tatsuya Miyoshi; Yuka Nagashima; Nao Shibata; Hiroko Yagi; Ryuji Fukuzawa; Tomonobu Hasegawa
Journal:  Hum Genome Var       Date:  2016-10-13

5.  Timing, rates and spectra of human germline mutation.

Authors:  Raheleh Rahbari; Arthur Wuster; Sarah J Lindsay; Robert J Hardwick; Ludmil B Alexandrov; Saeed Al Turki; Anna Dominiczak; Andrew Morris; David Porteous; Blair Smith; Michael R Stratton; Matthew E Hurles
Journal:  Nat Genet       Date:  2015-12-14       Impact factor: 38.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.